Lynch & Associates Walgreens Boots Alliance, Inc. Transaction History

Lynch & Associates

  • $429 Million
  • Q1 2024

A detailed history of Lynch & Associates transactions in Walgreens Boots Alliance, Inc. stock. As of the latest transaction made, Lynch & Associates holds 10,020 shares of WBA stock, worth $108,115. This represents 0.05% of its overall portfolio holdings.

Number of Shares
10,020
Previous 10,015 0.05%
Holding current value
$108,115
Previous $261,000 16.86%
% of portfolio
0.05%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 09, 2024
BUY
$20.51 - $26.65 $102 - $133
5 Added 0.05%
10,020 $217,000
Q4 2023

Jan 08, 2024
SELL
$19.94 - $26.64 $395,569 - $528,484
-19,838 Reduced 66.45%
10,015 $261,000
Q3 2023

Oct 24, 2023
SELL
$20.9 - $30.85 $63,870 - $94,277
-3,056 Reduced 9.29%
29,853 $663,000
Q2 2023

Oct 24, 2023
BUY
$28.37 - $36.31 $61,080 - $78,175
2,153 Added 7.0%
32,909 $937,000
Q2 2023

Jul 13, 2023
BUY
$28.37 - $36.31 $61,080 - $78,175
2,153 Added 7.0%
32,909 $938,000
Q1 2023

Oct 24, 2023
SELL
$32.33 - $37.71 $69,606 - $81,189
-2,153 Reduced 6.54%
30,756 $1.06 Million
Q1 2023

Apr 04, 2023
BUY
$32.33 - $37.71 $99,059 - $115,543
3,064 Added 11.06%
30,756 $1.06 Million
Q4 2022

Oct 24, 2023
SELL
$30.52 - $41.79 $65,953 - $90,308
-2,161 Reduced 7.24%
27,692 $1.03 Million
Q4 2022

Jan 05, 2023
BUY
$30.52 - $41.79 $57,163 - $78,272
1,873 Added 7.25%
27,692 $1.04 Million
Q3 2022

Oct 03, 2022
SELL
$31.4 - $42.04 $408,451 - $546,856
-13,008 Reduced 33.5%
25,819 $811,000
Q2 2022

Jul 06, 2022
SELL
$37.9 - $46.81 $11,104 - $13,715
-293 Reduced 0.75%
38,827 $1.47 Million
Q1 2022

Apr 08, 2022
SELL
$44.77 - $54.33 $90,256 - $109,529
-2,016 Reduced 4.9%
39,120 $1.75 Million
Q4 2021

Jan 11, 2022
SELL
$43.72 - $52.25 $150,702 - $180,105
-3,447 Reduced 7.73%
41,136 $2.15 Million
Q3 2021

Oct 12, 2021
SELL
$45.58 - $51.78 $67,914 - $77,152
-1,490 Reduced 3.23%
44,583 $2.1 Million
Q2 2021

Jul 21, 2021
SELL
$50.84 - $56.8 $122,473 - $136,831
-2,409 Reduced 4.97%
46,073 $2.42 Million
Q1 2021

Apr 09, 2021
BUY
$41.16 - $55.05 $88,082 - $117,807
2,140 Added 4.62%
48,482 $2.66 Million
Q4 2020

Jan 20, 2021
SELL
$33.52 - $44.1 $97,442 - $128,198
-2,907 Reduced 5.9%
46,342 $1.85 Million
Q3 2020

Oct 21, 2020
SELL
$34.67 - $43.16 $48,954 - $60,941
-1,412 Reduced 2.79%
49,249 $1.77 Million
Q2 2020

Jul 20, 2020
SELL
$38.35 - $47.02 $84,370 - $103,444
-2,200 Reduced 4.16%
50,661 $2.15 Million
Q1 2020

Apr 28, 2020
SELL
$41.02 - $59.59 $38,148 - $55,418
-930 Reduced 1.73%
52,861 $2.42 Million
Q4 2019

Jan 10, 2020
SELL
$52.08 - $62.72 $1,197 - $1,442
-23 Reduced 0.04%
53,791 $3.17 Million
Q3 2019

Oct 03, 2019
BUY
$49.29 - $58.06 $37,854 - $44,590
768 Added 1.45%
53,814 $2.98 Million
Q2 2019

Jul 19, 2019
SELL
$49.34 - $63.49 $569,877 - $733,309
-11,550 Reduced 17.88%
53,046 $2.9 Million
Q1 2019

Apr 25, 2019
BUY
$59.79 - $74.43 $43,586 - $54,259
729 Added 1.14%
64,596 $4.09 Million
Q4 2018

Jan 10, 2019
BUY
$65.26 - $85.69 $1.32 Million - $1.74 Million
20,260 Added 46.46%
63,867 $4.36 Million
Q3 2018

Oct 05, 2018
BUY
$60.76 - $73.81 $58,025 - $70,488
955 Added 2.24%
43,607 $3.18 Million
Q2 2018

Jul 09, 2018
SELL
$59.7 - $68.0 $29,850 - $34,000
-500 Reduced 1.16%
42,652 $2.56 Million
Q1 2018

Apr 06, 2018
SELL
$65.43 - $80.27 $68,701 - $84,283
-1,050 Reduced 2.38%
43,152 $2.83 Million
Q4 2017

Jan 04, 2018
SELL
$64.48 - $76.95 $104,780 - $125,043
-1,625 Reduced 3.55%
44,202 $3.21 Million
Q3 2017

Oct 18, 2017
BUY
$77.22 - $82.74 $3.54 Million - $3.79 Million
45,827
45,827 $3.54 Million

Others Institutions Holding WBA

# of Institutions
1,116
Shares Held
491M
Call Options Held
18.9M
Put Options Held
24M
View Full List

About Walgreens Boots Alliance, Inc.

WBA Quotes by TradingView
  • Ticker WBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Pharmaceutical Retailers
  • Shares Outstandng 864,812,992
  • Market Cap $9.33B
  • Description
  • Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products...
More about WBA
Track This Portfolio

Track Lynch & Associates Portfolio

Follow Lynch & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynch & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Lynch & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email